Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-24 @ 6:28 PM
NCT ID:
NCT03167268
Eligibility Criteria:
Standard schedules of these treatments would be used.
Inclusion and exclusion criteria would be the following:
Inclusion criteria:
1. Age ≥ 18 years;
2. Patients suffering from colorectal adenocarcinoma at stage-IV, for which a treatment with panitumumab is required;
3. No previous treatment with anti-EGFR drugs;
4. Presence of at least one neoplastic lesion one-dimensionally measurable;
5. No systemic anti-neoplastic therapy, nor experimental therapy or radiotherapy during the three weeks before randomization;
6. Proper contraceptive treatment by patient and his/her partner;
7. Written informed consent for participating to the study;
8. Performance Status (under ECOG scale) 0, 1. 2.
Exclusion criteria
1. PS \> 2
2. Poor patient compliance;
3. Dermatological ongoing pathologies which contraindicate the treatment or made skin toxicity assessment difficult;
4. Presence of clinical conditions which could alter lycopene absorption (altered intestinal transit, malabsorption);
5. Pregnancy;
6. Absence of measurable lesions;
7. Previous treatment with anti-EGFR drugs;
8. Intolerance/allergy to tomato or milk.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03167268
Study Brief:
Protocol Section:
NCT03167268